RxDoctor Payments Data

Kyle McClintock, DO

Orthopaedic Surgery · Roseville, CANPI 1477831527

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $68,113 of the $109,499 with a category attached, or 62.2%. 17 manufacturers reported payments, led by Zimmer Biomet at 40.8% of the total. 2025 is the largest year on record at $41,174, more than ten times the $1,811 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$109,499in general payments, 2019–2025

Across 89 payments — averaging $1230.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$45K
  • Shoulder Innovations, Inc.$33K
  • Genesis Software Innovations, LLC$21K
  • Embody, Inc.$6K
  • Evolution Surgical, Inc$1K
  • Arthrex$1K
  • plus $2K from 11 others
$52,795in ownership & investment interests, 2019–2025

Across 5 payments — averaging $10,559 each. An ownership or investment interest held by the physician or an immediate family member.

  • Genesis Software Innovations, LLC$53K

What the payments were for

  • Royalty or licence$68,11362%
  • Consulting fees$17,30016%
  • Travel & lodging$6,7276%
  • Food & beverage$2,0352%
  • Education$2,0242%
  • Gifts$7261%
  • Entertainment$350%
  • Ownership interest$12,54011%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$109,499 in reported general payments places this provider in the 90th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$296,145
Medicare patients
476
Services billed
2,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen84$738
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen46$573
Meloxicam220$495
Methylprednisolone49$290
Tramadol Hcl20$86
Amoxicillin36$67
Gabapentin11$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Roseville

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →